HIV/AIDS researcher David Katzenstein dies
The Stanford virologist conducted clinical vaccine trials, which led to the approval of antiretroviral drugs, greatly improving the survival of people living with HIV Feb 4 2021
David Katzenstein was widely praised for his efforts to bring better, cheaper methodologies to bear on HIV/AIDS prevention and treatment in Africa.
TeachAids
David Katzenstein, MD, professor emeritus of infectious diseases and global health at Stanford Medicine, who spurred advances in diagnosing, treating and preventing AIDS, died Jan. 25 of COVID-19 in Harare, Zimbabwe. He was 69.
Katzenstein was a trained virologist, clinician and tireless advocate for global health. He was widely praised for his energetic push to bring better, cheaper methodologies to bear on HIV/AIDS prevention and treatment in middle- and low-income African countries, where over a 35-year period he spearheaded numerous life-saving projects.